Literature DB >> 18941374

US mesothelioma patterns 1973-2002: indicators of change and insights into background rates.

Mary Jane Teta1, Pamela J Mink, Edmund Lau, Bonnielin K Sceurman, Edward D Foster.   

Abstract

Mesothelioma rates are declining toward background levels, although estimates of the background rate have varied. We expanded upon earlier analyses and provided a data-based estimate of the background rate. We analyzed US male and female patterns for five age groups using the National Cancer Institute's Surveillance Epidemiology and End Results registry data from 1973 to 2002. Age-specific and age-adjusted incidence rates per 1 000 000 persons per year, standardized to the 2000 US population, were calculated for total, pleural, and peritoneal mesothelioma. We also calculated rates for persons who attained working age after the US Occupational Safety and Health Administration asbestos exposure limits took effect. Mesothelioma rates observed among young males and females varied little over time. We observed a decline and convergence of recent male and female rates in older age groups, except those who are between the age of 60 and above, for whom the 2002 male rate was approximately five times greater than that of females. As expected, rates were higher in major shipyard areas on the West coast. Rates for persons with little or no opportunity for occupational asbestos exposure were 1.15 (95% confidence interval: 0.90-1.45) for men and 0.94 (95% confidence interval: 0.87-1.24) for women. Mesothelioma is rare in younger age groups, and rates have been relatively stable and similar for both sexes. Rates continue to decline in older age groups, but remain high for males at 60 years or older. Rates among females at older ages suggest an impact of occupational exposure. The background rate for persons below age 50 is approximately one per million, independent of sex. Future data are needed to estimate this rate for older age groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18941374     DOI: 10.1097/CEJ.0b013e3282f0c0a2

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  42 in total

1.  Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.

Authors:  Vanya Delgermaa; Ken Takahashi; Eun-Kee Park; Giang Vinh Le; Toshiyuki Hara; Tom Sorahan
Journal:  Bull World Health Organ       Date:  2011-06-13       Impact factor: 9.408

2.  Mesothelioma: a review.

Authors:  Frank E Mott
Journal:  Ochsner J       Date:  2012

3.  The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking.

Authors:  Samer A Naffouje; Kiara A Tulla; George I Salti
Journal:  Med Oncol       Date:  2018-04-12       Impact factor: 3.064

Review 4.  Medical treatment of mesothelioma: anything new?

Authors:  Nagio Takigawa; Katsuyuki Kiura; Takumi Kishimoto
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

Review 5.  Malignant peritoneal mesothelioma: a review.

Authors:  Joseph Kim; Shanel Bhagwandin; Daniel M Labow
Journal:  Ann Transl Med       Date:  2017-06

6.  Malignant mesothelioma: development to therapy.

Authors:  Joyce K Thompson; Catherine M Westbom; Arti Shukla
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

7.  Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis.

Authors:  Ahmad Raza; Blake A Jacobson; Adam Benoit; Manish R Patel; Joe Jay-Dixon; Hiroshi Hiasa; David M Ferguson; Robert Arthur Kratzke
Journal:  Invest New Drugs       Date:  2011-07-26       Impact factor: 3.850

8.  Expression of estrogen receptor beta (ERβ) and its prognostic value in pleural mesothelioma.

Authors:  Jeronimo Rafael Rodríguez-Cid; Orlando García-Acevedo; Javier Benjamin-Contreras; Diana Bonilla-Molina; Rodrigo Rafael Flores-Mariñelarena; Luis Martínez-Barrera; Jorge Arturo Alatorre-Alexander; Carla Paola Sanchez-Ríos; Maria Del Rosario Flores-Soto; Patricio Javier Santillan-Doherty; Erika Sagrario Peña-Mirabal
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

Review 9.  Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future.

Authors:  Ahmed Dehal; J Joshua Smith; Garrett M Nash
Journal:  J Gastrointest Oncol       Date:  2016-02

10.  Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.

Authors:  Marina Vivero; Raphael Bueno; Lucian R Chirieac
Journal:  Mod Pathol       Date:  2017-09-08       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.